Literature DB >> 14744576

Stimulus-response properties of motor system in patients with cerebellar ataxia.

Stefano Tamburin1, Antonio Fiaschi, Annalisa Andreoli, Silvia Marani, Paolo Manganotti, Giampietro Zanette.   

Abstract

OBJECTIVE: The aim of the study was to examine the stimulus-response properties of the excitatory and inhibitory components of corticospinal projections at rest and during voluntary contraction in cerebellar patients.
METHODS: We investigated motor evoked potential (MEP) and cortical silent period recruitment curves in response to increasing intensities of transcranial magnetic stimulation in 8 patients with 'pure' cerebellar syndromes and in 14 age-matched controls. The transcranial magnetic stimulation intensity was increased from 90 to 180% of the resting motor threshold. MEP recruitment curves were recorded at rest and during voluntary contraction in the right abductor pollicis brevis muscle.
RESULTS: No statistical differences were found between patients and controls in MEP recruitment curves in either the resting or active condition. A significant difference was found between patients and controls in the cortical silent period threshold (patients: 33.2+/-3.4% of maximal stimulator output; controls 39.4+/-3.2%; P=0.01) and recruitment curve, the duration of the cortical silent period being longer in patients at transcranial magnetic stimulation intensities ranging from 90 to 130% of the resting motor threshold (patients: 135-191 ms; controls: 53-158 ms). No changes were found in the silent period evoked by peripheral nerve stimulation.
CONCLUSIONS: Inhibitory components of corticospinal projections were recruited with a lower threshold in patients. No abnormalities were found in the recruitment of the excitatory networks. Our data show a prevalence of inhibitory phenomena in the motor cortex of cerebellar patients. These findings would appear to be specific to cerebellar diseases and are the opposite of those previously documented in movement disorders such as dystonia and Parkinson's disease. Our results suggest that the cerebellum and the basal ganglia may counteract each other in modulating the level of motor system excitability.

Entities:  

Mesh:

Year:  2004        PMID: 14744576     DOI: 10.1016/s1388-2457(03)00357-2

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  The EEG correlates of the TMS-induced EMG silent period in humans.

Authors:  Faranak Farzan; Mera S Barr; Sylco S Hoppenbrouwers; Paul B Fitzgerald; Robert Chen; Alvaro Pascual-Leone; Zafiris J Daskalakis
Journal:  Neuroimage       Date:  2013-06-22       Impact factor: 6.556

2.  Cerebellum tunes the excitability of the motor system: evidence from peripheral motor axons.

Authors:  Hiroyuki Nodera; Mario Manto
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

3.  Interhemispheric asymmetry of corticomotor excitability after chronic cerebellar infarcts.

Authors:  Suzete Nascimento Farias da Guarda; Leonardo G Cohen; Marco da Cunha Pinho; Fábio Iuji Yamamoto; Paulo Eurípedes Marchiori; Milberto Scaff; Adriana Bastos Conforto
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 4.  Emerging concepts in the physiological basis of dystonia.

Authors:  Angelo Quartarone; Mark Hallett
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

5.  Cerebellar transcranial magnetic stimulation facilitates excitability of spinal reflex, but does not affect cerebellar inhibition and facilitation in spinocerebellar ataxia.

Authors:  Akiyoshi Matsugi; Yutaka Kikuchi; Kenta Kaneko; Yuta Seko; Masato Odagaki
Journal:  Neuroreport       Date:  2018-07-04       Impact factor: 1.837

6.  Cerebellar Transcranial Magnetic Stimulation Reduces the Silent Period on Hand Muscle Electromyography During Force Control.

Authors:  Akiyoshi Matsugi; Shinya Douchi; Kodai Suzuki; Kosuke Oku; Nobuhiko Mori; Hiroaki Tanaka; Satoru Nishishita; Kyota Bando; Yutaka Kikuchi; Yohei Okada
Journal:  Brain Sci       Date:  2020-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.